Subscribe our Weekly Newsletter
Applications Invited for Unitaid Grant on Supporting the use of TRIPS flexibilities and other intellectual property-related solutions to facilitate access to health products
Organization: Unitaid
Apply By: 01 Feb 2023
About the Organization
Unitaid is a global health agency engaged in finding innovative solutions to prevent, diagnose, and treat diseases more quickly, cheaply and effectively, in low- and middle-income countries. Our work includes funding initiatives to address major diseases such as HIV/AIDS, malaria, and tuberculosis, as well as HIV co-infections and co-morbidities such as cervical cancer and hepatitis C, and cross-cutting areas, such as fever management.
Unitaid is now applying its expertise to address challenges in advancing new therapies and diagnostics for the COVID-19 pandemic, serving as a key member of the Access to COVID Tools Accelerator. Unitaid is hosted by the World Health Organization.
About the Grant
Unitaid is pleased to announce a new Call for Proposals on Supporting the use of TRIPS flexibilities and other intellectual property-related solutions to facilitate access to health products.
Unitaid aims to improve access to health products in low- and middle-income countries (LMICs). Unitaid recognizes that there are many determinants of access; intellectual property rights are one of them. The intellectual property system has been designed to incentivize innovation and has been effective in stimulating and rewarding innovation in several of the disease areas that Unitaid works on. But while patents can incentivize innovation, they also contribute to inequity in access to health products, as has been increasingly recognized in the aftermath of the COVID-19 pandemic. TRIPS flexibilities are intended to address this – and thereby represent an essential part of the intellectual property system.
The objective of this Call for Proposals is to continue and expand the use of TRIPS flexibilities and other solutions to prevent, overcome or remove unwarranted intellectual property barriers, in order to ensure affordability and availability of health products in LMICs. In particular, Unitaid is interested in ensuring the availability and affordability of health products [1] – including biologics – for HIV, TB, hepatitis C, and other diseases and conditions in alignment with the programmatic priorities outlined in Unitaid’s Strategy 2023-2027.
Interventions in scope include civil-society led efforts to implement and expand the use of TRIPS flexibilities; capacity building and technical support for the implementation of TRIPS flexibilities and other intellectual property-related solutions that facilitate access to health products; and work on intellectual property policies aiming to enhance supply security and support local or regional manufacturing. The objective of this work is to ensure equitable access to health products.
How to Apply
The closing date for receipt of full proposals is Wednesday 1 February 2023 at 12:00 (noon) CET. Applications received past the indicated deadline will not be considered.
Proposals, including all annexes, should be submitted electronically to proposalsUnitaid@who.int.
For more information please check the Link
Latest Online Store
Latest Tenders And EOIs
© Renalysis Consultants Pvt Ltd